Serum Cytokinome Profile Evaluation: A Tool to Define New Diagnostic and Prognostic Markers of Cancer Using Multiplexed Bead-Based Immunoassays
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Serum Cytokinome Profile Evaluation: A Tool to Define New Diagnostic and Prognostic Markers of Cancer Using Multiplexed Bead-Based Immunoassays
Authors
Keywords
-
Journal
MEDIATORS OF INFLAMMATION
Volume 2016, Issue -, Pages 1-11
Publisher
Hindawi Limited
Online
2016-12-07
DOI
10.1155/2016/3064643
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The tumor microenvironment and Immunoscore are critical determinants of dissemination to distant metastasis
- (2016) Bernhard Mlecnik et al. Science Translational Medicine
- TNF and ROS Crosstalk in Inflammation
- (2016) Heiko Blaser et al. TRENDS IN CELL BIOLOGY
- Novel Immunotherapeutic Avenues for Rheumatoid Arthritis
- (2016) Luca Semerano et al. TRENDS IN MOLECULAR MEDICINE
- Cytokine profile and prognostic significance of high neutrophil-lymphocyte ratio in colorectal cancer
- (2015) Z-Y Chen et al. BRITISH JOURNAL OF CANCER
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Plasma immune analytes in patients with epithelial ovarian cancer
- (2015) Matthew S. Block et al. CYTOKINE
- Tumor Microenvironment and Immunotherapy: The Whole Picture Is Better Than a Glimpse
- (2015) Sarah E. Church et al. IMMUNITY
- The Role of Cytokines in Breast Cancer Development and Progression
- (2015) Marcela Esquivel-Velázquez et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Pazopanib as Third Line Therapy for Metastatic Renal Cell Carcinoma: Clinical Efficacy and Temporal Analysis of Cytokine Profile
- (2015) Sumanta Kumar Pal et al. JOURNAL OF UROLOGY
- Cytokines as Mediators of Pain-Related Process in Breast Cancer
- (2015) Carolina Panis et al. MEDIATORS OF INFLAMMATION
- The Cytokinome Profile in Patients with Hepatocellular Carcinoma and Type 2 Diabetes
- (2015) Francesca Capone et al. PLoS One
- Novel Approaches to Treatment of Advanced Melanoma: A Review on Targeted Therapy and Immunotherapy
- (2015) Anna Niezgoda et al. Biomed Research International
- Cytokine profile determined by data-mining analysis set into clusters of non-small-cell lung cancer patients according to prognosis
- (2014) L. Barrera et al. ANNALS OF ONCOLOGY
- Interleukins as markers of inflammation in malignant and benign thyroid disease
- (2014) Xeni Provatopoulou et al. INFLAMMATION RESEARCH
- A prognostic classifier consisting of 17 circulating cytokines is a novel predictor of overall survival for metastatic colorectal cancer patients
- (2014) Zhi-Yuan Chen et al. INTERNATIONAL JOURNAL OF CANCER
- Ovarian cancer
- (2014) Gordon C Jayson et al. LANCET
- Epigenomic alterations define lethal CIMP-positive ependymomas of infancy
- (2014) S. C. Mack et al. NATURE
- Tumours outside the mutation box
- (2014) Rogier Versteeg NATURE
- C11orf95–RELA fusions drive oncogenic NF-κB signalling in ependymoma
- (2014) Matthew Parker et al. NATURE
- Selected Cytokines in Patients with Pancreatic Cancer: A Preliminary Report
- (2014) Wojciech Błogowski et al. PLoS One
- Circulating levels of immune and inflammatory markers and long versus short survival in early-stage lung cancer
- (2013) C. Bodelon et al. ANNALS OF ONCOLOGY
- Plasma Cytokine Analysis in Patients with Advanced Extremity Melanoma Undergoing Isolated Limb Infusion
- (2013) Gina Shetty et al. ANNALS OF SURGICAL ONCOLOGY
- Regulatory T cells, interleukin (IL)-6, IL-8, Vascular endothelial growth factor (VEGF), CXCL10, CXCL11, epidermal growth factor (EGF) and hepatocyte growth factor (HGF) as surrogate markers of host immunity in patients with renal cell carcinoma
- (2013) Marianeve Polimeno et al. BJU INTERNATIONAL
- Circulating cytokines and gastric cancer risk
- (2013) Meira Epplein et al. CANCER CAUSES & CONTROL
- Profiles of circulating inflammatory cytokines in colorectal cancer (CRC), high cancer risk conditions, and health are distinct. Possible implications for CRC screening and surveillance
- (2013) Malgorzata Krzystek-Korpacka et al. CANCER LETTERS
- The Epidemiology of Pancreatitis and Pancreatic Cancer
- (2013) Dhiraj Yadav et al. GASTROENTEROLOGY
- Synergistic Activation of Inflammatory Cytokine Genes by Interferon-γ-Induced Chromatin Remodeling and Toll-like Receptor Signaling
- (2013) Yu Qiao et al. IMMUNITY
- Circulating Inflammation Markers and Prospective Risk for Lung Cancer
- (2013) Meredith S. Shiels et al. JNCI-Journal of the National Cancer Institute
- How Cytokine Networks Fuel Inflammation: Toward a cytokine-based disease taxonomy
- (2013) Georg Schett et al. NATURE MEDICINE
- An Agent-Based Model of Cellular Dynamics and Circadian Variability in Human Endotoxemia
- (2013) Tung T. Nguyen et al. PLoS One
- Cancer Genome Landscapes
- (2013) B. Vogelstein et al. SCIENCE
- Editorial: Hepatocellular Carcinoma in Type 2 Diabetes: More Than Meets the Eye
- (2012) György Baffy AMERICAN JOURNAL OF GASTROENTEROLOGY
- Human prostate cancer cells induce inflammatory cytokine secretion by peripheral blood mononuclear cells
- (2012) Hertzel Salman et al. BIOMEDICINE & PHARMACOTHERAPY
- Stage-dependent alterations of the serum cytokine pattern in colorectal carcinoma
- (2012) T Kantola et al. BRITISH JOURNAL OF CANCER
- Differential oxidative status and immune characterization of the early and advanced stages of human breast cancer
- (2011) C. Panis et al. BREAST CANCER RESEARCH AND TREATMENT
- Evaluation of Multiplexed Cytokine and Inflammation Marker Measurements: a Methodologic Study
- (2011) A. K. Chaturvedi et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13
- (2011) Rachel F. Gabitass et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Increased Levels of Circulating Interleukin 6, Interleukin 8, C-Reactive Protein, and Risk of Lung Cancer
- (2011) Sharon R. Pine et al. JNCI-Journal of the National Cancer Institute
- The Pathogenesis of Rheumatoid Arthritis
- (2011) Iain B. McInnes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Serum cytokine profiles in patients with prostate carcinoma
- (2011) ERI TAZAKI et al. Experimental and Therapeutic Medicine
- Pattern Recognition Receptors and Inflammation
- (2010) Osamu Takeuchi et al. CELL
- Immunity, Inflammation, and Cancer
- (2010) Sergei I. Grivennikov et al. CELL
- The changing pattern of epidemiology in hepatocellular carcinoma
- (2010) Helena Nordenstedt et al. DIGESTIVE AND LIVER DISEASE
- Hepatocellular Carcinoma: Epidemiology, Surveillance, and Diagnosis
- (2010) Morris Sherman SEMINARS IN LIVER DISEASE
- Estimating Risk of Recurrence in Differentiated Thyroid Cancer After Total Thyroidectomy and Radioactive Iodine Remnant Ablation: Using Response to Therapy Variables to Modify the Initial Risk Estimates Predicted by the New American Thyroid Association Staging System
- (2010) R. Michael Tuttle et al. THYROID
- Cytokines and angiogenic factors in patients with metastatic renal cell carcinoma treated with interferon- : association of pretreatment serum levels with survival
- (2009) A. J. Montero et al. ANNALS OF ONCOLOGY
- The dynamics of macrophage lineage populations in inflammatory and autoimmune diseases
- (2009) John A. Hamilton et al. ARTHRITIS AND RHEUMATISM
- Cross-regulation of Signaling Pathways by Interferon-γ: Implications for Immune Responses and Autoimmune Diseases
- (2009) Xiaoyu Hu et al. IMMUNITY
- An approach for understanding the inflammation and cancer relationship
- (2009) S. Costantini et al. IMMUNOLOGY LETTERS
- Cytokines as a key component of cancer-related inflammation
- (2008) Giovanni Germano et al. CYTOKINE
- Multiplex analysis of cytokines as biomarkers that differentiate benign and malignant thyroid diseases
- (2008) Faina Linkov et al. Proteomics Clinical Applications
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started